Alemtuzumab for Multiples Sclerosis: Who and When to treat?Lancet 380:1795-1797, 1792, Springer, T. & Kappos, L., 2012
Randomized Trial of Oral Teriflunomide for Relapsing Multiple SclerosisNEJM 365:1293-1303, OConnor, P.,et al, 2011